Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis
Clinical trial NCT04440592 · COMPLETED
Trial details
- NCT number
- NCT04440592
- Sponsor
- Tanabe Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-05
- Primary completion
- 2024-01-17
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.